Cytokinetics Inc Cash Flow Reinvestment Rate
Cytokinetics Inc cash flow reinvestment rate. Cytokinetics Inc (CYTK) has a Cash Flow Reinvestment Rate of 3.33x as of December 2020, reinvesting $173.62 Million (capex $6.55 Million plus investments $-167.06 Million) from operating cash flow of $52.15 Million. Explore Cytokinetics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cytokinetics Inc (2009–2020)
Cash flow reinvestment rate of Cytokinetics Inc from 2009 to 2020. Historical reinvestment intensity for Cytokinetics Inc across 4 annual periods. Explore Cytokinetics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Cytokinetics Inc Cash Flow Reinvestment Rate by Year (2009–2020)
Cytokinetics Inc cash flow reinvestment rate by year from 2009 to 2020. Year-by-year capital reinvestment analysis for Cytokinetics Inc. For the full cash flow conversion analysis, see Cytokinetics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 21.97x | $196.51 Million | $8.94 Million | $11.05 Million | ▲ +1459.5% |
| 2016 | 1.41x | $52.11 Million | $36.98 Million | $1.60 Million | ▼ -60.0% |
| 2015 | 3.52x | $17.19 Million | $4.88 Million | $562.00K | ▲ +5285.6% |
| 2009 | 0.07x | $550.00K | $8.42 Million | $550.00K | — |